Logo image of ESF0.DE

EUROFINS SCIENTIFIC (ESF0.DE) Stock Fundamental Analysis

Europe - Frankfurt Stock Exchange - FRA:ESF0 - FR0014000MR3 - Common Stock

71.98 EUR
-0.74 (-1.02%)
Last: 1/14/2026, 7:00:00 PM
Fundamental Rating

5

Overall ESF0 gets a fundamental rating of 5 out of 10. We evaluated ESF0 against 22 industry peers in the Life Sciences Tools & Services industry. Both the profitability and the financial health of ESF0 get a neutral evaluation. Nothing too spectacular is happening here. ESF0 is not valued too expensively and it also shows a decent growth rate.


Dividend Valuation Growth Profitability Health

6

1. Profitability

1.1 Basic Checks

  • ESF0 had positive earnings in the past year.
  • In the past year ESF0 had a positive cash flow from operations.
  • In the past 5 years ESF0 has always been profitable.
  • In the past 5 years ESF0 always reported a positive cash flow from operatings.
ESF0.DE Yearly Net Income VS EBIT VS OCF VS FCFESF0.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B

1.2 Ratios

  • ESF0's Return On Assets of 3.54% is in line compared to the rest of the industry. ESF0 outperforms 50.00% of its industry peers.
  • ESF0 has a Return On Equity of 8.09%. This is in the better half of the industry: ESF0 outperforms 63.64% of its industry peers.
  • The Return On Invested Capital of ESF0 (9.79%) is better than 77.27% of its industry peers.
  • ESF0 had an Average Return On Invested Capital over the past 3 years of 8.70%. This is in line with the industry average of 9.34%.
  • The last Return On Invested Capital (9.79%) for ESF0 is above the 3 year average (8.70%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 3.54%
ROE 8.09%
ROIC 9.79%
ROA(3y)3.79%
ROA(5y)5.05%
ROE(3y)7.94%
ROE(5y)10.72%
ROIC(3y)8.7%
ROIC(5y)10.54%
ESF0.DE Yearly ROA, ROE, ROICESF0.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15

1.3 Margins

  • ESF0's Profit Margin of 5.44% is in line compared to the rest of the industry. ESF0 outperforms 40.91% of its industry peers.
  • In the last couple of years the Profit Margin of ESF0 has grown nicely.
  • The Operating Margin of ESF0 (15.59%) is comparable to the rest of the industry.
  • ESF0's Operating Margin has improved in the last couple of years.
  • ESF0 has a worse Gross Margin (23.29%) than 77.27% of its industry peers.
  • ESF0's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 15.59%
PM (TTM) 5.44%
GM 23.29%
OM growth 3Y-11.93%
OM growth 5Y3.56%
PM growth 3Y-23.05%
PM growth 5Y9.75%
GM growth 3Y-7.6%
GM growth 5Y1.83%
ESF0.DE Yearly Profit, Operating, Gross MarginsESF0.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15 20 25

5

2. Health

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so ESF0 is still creating some value.
  • The number of shares outstanding for ESF0 has been reduced compared to 1 year ago.
  • Compared to 5 years ago, ESF0 has more shares outstanding
  • ESF0 has a better debt/assets ratio than last year.
ESF0.DE Yearly Shares OutstandingESF0.DE Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M
ESF0.DE Yearly Total Debt VS Total AssetsESF0.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B 10B

2.2 Solvency

  • ESF0 has an Altman-Z score of 2.89. This is not the best score and indicates that ESF0 is in the grey zone with still only limited risk for bankruptcy at the moment.
  • ESF0 has a Altman-Z score (2.89) which is in line with its industry peers.
  • ESF0 has a debt to FCF ratio of 5.24. This is a neutral value as ESF0 would need 5.24 years to pay back of all of its debts.
  • The Debt to FCF ratio of ESF0 (5.24) is better than 63.64% of its industry peers.
  • A Debt/Equity ratio of 0.77 indicates that ESF0 is somewhat dependend on debt financing.
  • Looking at the Debt to Equity ratio, with a value of 0.77, ESF0 is in line with its industry, outperforming 40.91% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.77
Debt/FCF 5.24
Altman-Z 2.89
ROIC/WACC1.16
WACC8.47%
ESF0.DE Yearly LT Debt VS Equity VS FCFESF0.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B 4B 5B

2.3 Liquidity

  • ESF0 has a Current Ratio of 1.26. This is a normal value and indicates that ESF0 is financially healthy and should not expect problems in meeting its short term obligations.
  • ESF0 has a Current ratio (1.26) which is in line with its industry peers.
  • ESF0 has a Quick Ratio of 1.19. This is a normal value and indicates that ESF0 is financially healthy and should not expect problems in meeting its short term obligations.
  • The Quick ratio of ESF0 (1.19) is better than 86.36% of its industry peers.
Industry RankSector Rank
Current Ratio 1.26
Quick Ratio 1.19
ESF0.DE Yearly Current Assets VS Current LiabilitesESF0.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B

5

3. Growth

3.1 Past

  • The Earnings Per Share has grown by an nice 16.50% over the past year.
  • ESF0 shows quite a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 18.34% yearly.
  • The Revenue has been growing slightly by 2.53% in the past year.
  • Measured over the past years, ESF0 shows a quite strong growth in Revenue. The Revenue has been growing by 8.78% on average per year.
EPS 1Y (TTM)16.5%
EPS 3Y-21.42%
EPS 5Y18.34%
EPS Q2Q%19.61%
Revenue 1Y (TTM)2.53%
Revenue growth 3Y1.14%
Revenue growth 5Y8.78%
Sales Q2Q%5.64%

3.2 Future

  • ESF0 is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 15.68% yearly.
  • Based on estimates for the next years, ESF0 will show a small growth in Revenue. The Revenue will grow by 7.25% on average per year.
EPS Next Y14.67%
EPS Next 2Y13.53%
EPS Next 3Y13.98%
EPS Next 5Y15.68%
Revenue Next Year5.1%
Revenue Next 2Y5.44%
Revenue Next 3Y5.93%
Revenue Next 5Y7.25%

3.3 Evolution

  • The EPS growth rate is stable: in the next years the growth will be about the same than in the last years.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
ESF0.DE Yearly Revenue VS EstimatesESF0.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2B 4B 6B 8B
ESF0.DE Yearly EPS VS EstimatesESF0.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2 4 6

6

4. Valuation

4.1 Price/Earnings Ratio

  • Based on the Price/Earnings ratio of 19.99, the valuation of ESF0 can be described as rather expensive.
  • Based on the Price/Earnings ratio, ESF0 is valued cheaply inside the industry as 81.82% of the companies are valued more expensively.
  • Compared to an average S&P500 Price/Earnings ratio of 27.33, ESF0 is valued a bit cheaper.
  • The Price/Forward Earnings ratio is 18.08, which indicates a rather expensive current valuation of ESF0.
  • ESF0's Price/Forward Earnings ratio is rather cheap when compared to the industry. ESF0 is cheaper than 81.82% of the companies in the same industry.
  • ESF0 is valuated rather cheaply when we compare the Price/Forward Earnings ratio to 24.12, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 19.99
Fwd PE 18.08
ESF0.DE Price Earnings VS Forward Price EarningsESF0.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

  • 86.36% of the companies in the same industry are more expensive than ESF0, based on the Enterprise Value to EBITDA ratio.
  • 95.45% of the companies in the same industry are more expensive than ESF0, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 16.71
EV/EBITDA 9.77
ESF0.DE Per share dataESF0.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 20 30

4.3 Compensation for Growth

  • ESF0's PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
  • ESF0 has a very decent profitability rating, which may justify a higher PE ratio.
  • ESF0's earnings are expected to grow with 13.98% in the coming years. This may justify a more expensive valuation.
PEG (NY)1.36
PEG (5Y)1.09
EPS Next 2Y13.53%
EPS Next 3Y13.98%

4

5. Dividend

5.1 Amount

  • ESF0 has a yearly dividend return of 0.87%, which is pretty low.
  • Compared to an average industry Dividend Yield of 0.54, ESF0 pays a better dividend. On top of this ESF0 pays more dividend than 81.82% of the companies listed in the same industry.
  • Compared to an average S&P500 Dividend Yield of 1.91, ESF0's dividend is way lower than the S&P500 average.
Industry RankSector Rank
Dividend Yield 0.87%

5.2 History

  • The dividend of ESF0 is nicely growing with an annual growth rate of 16.51%!
Dividend Growth(5Y)16.51%
Div Incr Years1
Div Non Decr Years1
ESF0.DE Yearly Dividends per shareESF0.DE Yearly Dividends per shareYearly Dividends per share 2022 2023 2024 2025 0.2 0.4 0.6 0.8

5.3 Sustainability

  • 54.88% of the earnings are spent on dividend by ESF0. This is a bit on the high side, but may be sustainable.
  • ESF0's earnings are growing slower than its dividend. This means the dividend growth is not sustainable.
DP54.88%
EPS Next 2Y13.53%
EPS Next 3Y13.98%
ESF0.DE Yearly Income VS Free CF VS DividendESF0.DE Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B
ESF0.DE Dividend Payout.ESF0.DE Dividend Payout, showing the Payout Ratio.ESF0.DE Dividend Payout.PayoutRetained Earnings

EUROFINS SCIENTIFIC

FRA:ESF0 (1/14/2026, 7:00:00 PM)

71.98

-0.74 (-1.02%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryLife Sciences Tools & Services
Earnings (Last)10-21
Earnings (Next)01-29
Inst Owners35.61%
Inst Owner ChangeN/A
Ins Owners0%
Ins Owner ChangeN/A
Market Cap13.11B
Revenue(TTM)6.89B
Net Income(TTM)375.00M
Analysts68.42
Price Target66.09 (-8.18%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0.87%
Yearly Dividend0.52
Dividend Growth(5Y)16.51%
DP54.88%
Div Incr Years1
Div Non Decr Years1
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0.41%
PT rev (3m)1.29%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0.2%
EPS NY rev (3m)-0.08%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0.03%
Revenue NY rev (3m)-0.32%
Valuation
Industry RankSector Rank
PE 19.99
Fwd PE 18.08
P/S 1.9
P/FCF 16.71
P/OCF 9.97
P/B 2.83
P/tB N/A
EV/EBITDA 9.77
EPS(TTM)3.6
EY5%
EPS(NY)3.98
Fwd EY5.53%
FCF(TTM)4.31
FCFY5.98%
OCF(TTM)7.22
OCFY10.03%
SpS37.84
BVpS25.45
TBVpS-3.69
PEG (NY)1.36
PEG (5Y)1.09
Graham Number45.4
Profitability
Industry RankSector Rank
ROA 3.54%
ROE 8.09%
ROCE 12.65%
ROIC 9.79%
ROICexc 10.74%
ROICexgc 34.11%
OM 15.59%
PM (TTM) 5.44%
GM 23.29%
FCFM 11.38%
ROA(3y)3.79%
ROA(5y)5.05%
ROE(3y)7.94%
ROE(5y)10.72%
ROIC(3y)8.7%
ROIC(5y)10.54%
ROICexc(3y)9.52%
ROICexc(5y)11.6%
ROICexgc(3y)31.02%
ROICexgc(5y)39.55%
ROCE(3y)11.31%
ROCE(5y)13.7%
ROICexgc growth 3Y-18.17%
ROICexgc growth 5Y3.78%
ROICexc growth 3Y-15.5%
ROICexc growth 5Y6.63%
OM growth 3Y-11.93%
OM growth 5Y3.56%
PM growth 3Y-23.05%
PM growth 5Y9.75%
GM growth 3Y-7.6%
GM growth 5Y1.83%
F-Score7
Asset Turnover0.65
Health
Industry RankSector Rank
Debt/Equity 0.77
Debt/FCF 5.24
Debt/EBITDA 2.1
Cap/Depr 84.98%
Cap/Sales 7.7%
Interest Coverage 9.99
Cash Conversion 77.4%
Profit Quality 209.23%
Current Ratio 1.26
Quick Ratio 1.19
Altman-Z 2.89
F-Score7
WACC8.47%
ROIC/WACC1.16
Cap/Depr(3y)89.21%
Cap/Depr(5y)85.64%
Cap/Sales(3y)8.63%
Cap/Sales(5y)7.99%
Profit Quality(3y)162.79%
Profit Quality(5y)158.88%
High Growth Momentum
Growth
EPS 1Y (TTM)16.5%
EPS 3Y-21.42%
EPS 5Y18.34%
EPS Q2Q%19.61%
EPS Next Y14.67%
EPS Next 2Y13.53%
EPS Next 3Y13.98%
EPS Next 5Y15.68%
Revenue 1Y (TTM)2.53%
Revenue growth 3Y1.14%
Revenue growth 5Y8.78%
Sales Q2Q%5.64%
Revenue Next Year5.1%
Revenue Next 2Y5.44%
Revenue Next 3Y5.93%
Revenue Next 5Y7.25%
EBIT growth 1Y14.06%
EBIT growth 3Y-10.93%
EBIT growth 5Y12.66%
EBIT Next Year83.84%
EBIT Next 3Y29.91%
EBIT Next 5Y21.82%
FCF growth 1Y113.26%
FCF growth 3Y-7.69%
FCF growth 5Y25.62%
OCF growth 1Y31.36%
OCF growth 3Y-4.44%
OCF growth 5Y14.24%

EUROFINS SCIENTIFIC / ESF0.DE FAQ

What is the ChartMill fundamental rating of EUROFINS SCIENTIFIC (ESF0.DE) stock?

ChartMill assigns a fundamental rating of 5 / 10 to ESF0.DE.


What is the valuation status for ESF0 stock?

ChartMill assigns a valuation rating of 6 / 10 to EUROFINS SCIENTIFIC (ESF0.DE). This can be considered as Fairly Valued.


What is the profitability of ESF0 stock?

EUROFINS SCIENTIFIC (ESF0.DE) has a profitability rating of 6 / 10.


What are the PE and PB ratios of EUROFINS SCIENTIFIC (ESF0.DE) stock?

The Price/Earnings (PE) ratio for EUROFINS SCIENTIFIC (ESF0.DE) is 19.99 and the Price/Book (PB) ratio is 2.83.


How sustainable is the dividend of EUROFINS SCIENTIFIC (ESF0.DE) stock?

The dividend rating of EUROFINS SCIENTIFIC (ESF0.DE) is 4 / 10 and the dividend payout ratio is 54.88%.